This week, Spyre will attend the 2024 Jefferies Global Healthcare Conference, where our CEO Cameron Turtle will participate in a fireside chat and our team will host investor meetings regarding our investigational next-generation treatment options for patients with inflammatory bowel disease. To learn more about our approach and watch the live webcast, head to ir.spyre.com. #JefferiesHealthcare #IBD
Spyre Therapeutics’ Post
More Relevant Posts
-
Discover the future of healthcare with precision medicine at Granger Pharmacy! 🩺✨ Partnering with physicians, we deliver personalized treatments tailored just for you. Experience reduced side effects, enhanced efficiency, and improved disease management. Visit www.grangerrx.com today to learn more. #PrecisionMedicine #GrangerPharmacy #PersonalizedCare #HealthcareInnovation
To view or add a comment, sign in
-
June 21-23, 2024! #TampaFL JOIN SP-Foundation make some NOISE for #spasticparaplegia. A rare disease group needs every member to help grow awareness. The 2024 SPF #HSPandPLS Annual Conference brings together patients, physicians, and researchers to really see YOU! Come share your story with others register online for in-person 21-23, 2024 or virtually! #hspandpls #spasticparaplegiafoundation #awarenesshspandpls #releasecures #curehspandpls #disabilityawareness #patientadvocate #patienteducation #findacure #championcures #releasecures
To view or add a comment, sign in
-
In Crohn’s disease (CD), evolving management goals emphasize a treat-to-target approach. The STRIDE II consensus, developed by healthcare providers (HCPs), aims for endoscopic healing and clinical remission. However, survey data reveal that HCPs and patients may differ in perspectives on symptoms like bowel urgency and fatigue. Addressing these patient experiences is essential for comprehensive CD management. HCPs can learn more here: https://e.lilly/3W94Oa0
To view or add a comment, sign in
-
June 21-23, 2024! #TampaFL JOIN SP-Foundation make some NOISE for #spasticparaplegia. A rare disease group needs every member to help grow awareness. The 2024 SPF #HSPandPLS Annual Conference brings together patients, physicians, and researchers to really see YOU! Come share your story with others register online for in-person 21-23, 2024 or virtually! #hspandpls #spasticparaplegiafoundation #awarenesshspandpls #releasecures #curehspandpls #disabilityawareness #patientadvocate #patienteducation #findacure #championcures #releasecures
To view or add a comment, sign in
-
#ICYMI: We presented at #JPM24 last week and shared the latest on Tenaya’s progress across our pipeline. Watch the presentation here: https://bit.ly/3tZ8hfA
Next week, Tenaya’s Chief Executive Officer Faraz Ali will present at the 42nd Annual J.P. Morgan Healthcare Conference. We’re looking forward to sharing the latest on Tenaya’s progress in advancing therapies that address the underlying drivers of heart disease. Read today’s press release for full presentation details: https://bit.ly/3tOGDln #JPM24
To view or add a comment, sign in
-
It’s the FDA's virtual public meeting today, in global observance of Rare Disease Week. This event brings together patients, healthcare professionals, and industry leaders to discuss vital topics impacting rare disease research and treatment. We're looking forward to attending and gaining valuable insights to further our mission of improving patient outcomes. #RareDiseaseWeek #FDAEvent #RareDiseaseResearch #RareDiseaseAwareness
To view or add a comment, sign in
-
Infusion Leader Designing Solutions for Home Infusion & Ambulatory Infusion Centers | Advancing Infusion Excellence for Home, Specialty, Oncology & Biologic Therapies | Consultant | Board Member | Fractional Leadership
The success story I shared in this article changed my way of thinking with regard to Ig therapy management. More importantly, it changed my patient’s life by reducing time dedicated to treatment and the days following the infusion that evaporated as a result of intolerable adverse effects. I hope it helps you when that next difficult Ig management situation arises. Please feel free to reach out if there is anything I can do to help navigate your Ig patients’ treatment challenges. I’m here to help.
The May/June issue INFUSION, published by National Home Infusion Association, has timely information for the care of our home immunotherapy patients. Considering that PID sufferers normally endure more than a decade of recurrent respiratory illnesses before obtaining a diagnosis, losing even more time from their daily routine because of intolerable adverse effects of IVIg is unacceptable. The article focused around identifying and transitioning appropriate candidates from IVIg to SCIg can help you guide patients through the switch and maximize the chances of successful treatment for their disease. Please reach out if we can help with any challenging patient care issues or guide you in your team’s training. We’re here to help.
To view or add a comment, sign in
-
At AstraZeneca, we are continuing to follow the science to further unlock our understanding of complex immune-driven diseases like SLE. If we can recognize and address the underlying drivers of disease, we can tackle key areas of unmet need that remain. On #WorldLupusDay let’s shed light on the urgent need for higher standards of lupus care. Together, we can take action to advance the existing standard of care and help those with lupus lead fuller lives. #MakeLupusVisible #UnlockingLupus #WorldLupusDay #AstraZenecaEgypt
The tide is turning in lupus care, with recent updates to clinical guidelines highlighting remission as a key care goal. For patients, time in remission, free from symptoms, would be transformational. We are collaborating with the lupus community to make this possible. Learn more: https://learn.az/6040jqtD6 #WorldLupusDay #MakeLupusVisible
To view or add a comment, sign in
-
Are you missing out on possibly $60K worth of potential revenue? With Medicare failing to keep up with the rising cost of care, many practices are left to find means to sustain their businesses while providing quality care to patients. Clinimetrix can help practices like yours identify missed revenue opportunities while ensuring the high quality of care your patients deserve. For instance, it provides you with the opportunity to identify the number of patients with active chronic diseases but no Chronic Disease Management (CDM) plan. Based on our data, we have found that for every 1000 patients, you could potentially be missing out on approximately $60K worth of potential revenue from chronic disease billings. Are you interested in learning more about how Clinimetrix can help increase your practice's revenue without compromising the quality of care you provide? Book a FREE demo session with us today. ➡https://lnkd.in/e4HF6HqY
To view or add a comment, sign in
-
Facing Inflammatory Bowel Disease (IBD) can be daunting, but you don't have to navigate it solo. As we approach World IBD Day on May 19th, we're thrilled to announce our partnership with TrueHLTH, providing invaluable support for individuals like you. From insurance navigation to understanding medical bills, our dedicated advocates are here to lend a helping hand. Take the first step towards empowerment and support by joining forces with TrueHLTH this World IBD Day. Together, we can conquer IBD challenges! https://lnkd.in/gWS74nt3
To view or add a comment, sign in
8,012 followers